KLK3 and prostate carcinoma: At each time point, we enumerated CTCs from the blood, collected PSA values and investigated the nuclear 3D telomere architecture in CTCs derived from patients with non-metastatic high-risk prostate cancer before, post-ADT, and post-RT [19].